Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells

Molecular Membrane Biology

Volumn 16, Issue 1, 1999, Pages 111-118

  Düzgüneş, Nejat ^a   Pretzer, Elizabeth ^a,d   Simões, Sérgio ^a,b   Slepushkin, Vladimir ^a,e   Konopka, Krystyna ^a   Flasher, Diana ^a,f   Pedroso De Lima, Maria C ^c  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d ILLUMINA INC   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Antisense oligonucleotide; Gene therapy; pH sensitive liposomes; PMEA; Ribozyme; Sterically stabilized liposomes

Indexed keywords

ADEFOVIR; ANTISENSE OLIGONUCLEOTIDE; ANTIVIRUS AGENT; CD4 ANTIGEN; CHOLESTRYLHEMISUCCINATE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DIPHTHERIA TOXIN; L 689502; LIPOSOME; MACROGOL; PHOSPHATIDYLETHANOLAMINE; PROTEINASE INHIBITOR; REV PROTEIN; RIBOZYME; RNA DIRECTED DNA POLYMERASE INHIBITOR; SUCCINIC ACID DERIVATIVE; TRANSFERRIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; CONFERENCE PAPER; DNA TRANSFECTION; DRUG DELIVERY SYSTEM; ENCAPSULATION; GENE TARGETING; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; PRIORITY JOURNAL; VIRUS GENE;

EID: 0032899408     PISSN: 09687688     EISSN: None     Source Type: Journal    
DOI: 10.1080/096876899294832     Document Type: Conference Paper

References (72)

1. Ashkenazi, A., Smith, D. H., Marsters, S. A., Riddle, L., Gregory, T. J., Ho, D. D. and Capon, D. J., 1991, Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. Proceedings of the National Academy of Sciences (USA), 88, 7056-7060.
2. Ashorn, P., McQuade, T. J., Thaisrivongs, S., Tomasselli, A. G., Tarpley, W. G. and Moss, B., 1990, An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Proceedings of the National Academy of Sciences (USA), 87, 7472-7476.
3. Balzarini, J., Karlsson, A., Pérez-Pérez, M.-J., Camarasa, M.-J. and De Clercq, E., 1993, Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus. Virology, 196, 576-585.
4. Balzarini, J., Perno, C.-F., Schols, D. and De Clercq, E., 1991, Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes. Biochemical and Biophysical Research Communications, 178, 329-335.
5. Bridges, S. H. and Sarver, N., 1995, Gene therapy and immune restoration for HIV disease. Lancet, 345, 427-432.
6. Brighty, D. W., Rosenberg, M., Chen, I. S. Y. and Ivey-Hoyle, M., 1991, Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor. Proceedings of the National Academy of Sciences (USA), 88, 7802-7805.
7. Cantin, E. M. and Woolf, T. M., 1993, Antisense oligonucleotides as antiviral agents: prospects and problems. Trends in Microbiology, 1, 270-276.
8. Cheng, P. W., 1996, Receptor ligand-facilitated gene transfer: Enhancement of liposome-mediated gene transfer and expression by transferrin. Human Gene Therapy, 7, 275-282.
9. Chu, C.-J., Dijkstra, J., Lai, M.-Z., Hong, K. and Szoka, F. C., 1990, Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture. Pharmaceutical Research, 7, 824-834.
10. Connor, J. and Huang, L., 1985, Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive liposomes. Journal of Cell Biology, 101, 582-589.
11. Connor, J., Yatvin, M. B. and Huang, L., 1984, pH-sensitive liposomes: Acid-induced liposome fusion. Proceedings of the National Academy of Sciences (USA), 81, 1715-1718.
12. Daar, E. S., Li, X. L., Moudgil, T. and Ho, D. D., 1990, High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proceedings of the National Academy of Sciences (USA), 87, 6574-6578.
13. De Clercq, E., 1995, Antiviral therapy for human immunodeficiency virus infections. Clinical Microbiology Reviews, 8, 200-239.
14. Deen, K. C., McDougal, J. S., Inacker, R., Folena-Wasserman, G., Arthos, J., Rosenberg, J., Maddon, P. J., Axel, R. and Sweet, R., 1988, A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature, 331, 82-84.
15. Düzgüneş, N. and Felgner, P. L., 1993, Intracellular delivery of nucleic acids and transcription factors by cationic liposomes. Methods in Enzymology, 221, 303-306.
16. Düzgüneş, N., Flasher, D., Pretzer, E., Konopka, K., Slepushkin, V. A., Steffan, G., Salem, I. I., Reddy, M. V. and Gangadharam, P. R. J., 1995, Liposome-mediated therapy of human immunodeficiency virus type-1 and mycobacterium infections. Journal of Liposome Research, 5, 669-691.
17. Düzgüneş, N., Straubinger, R. M., Baldwin, P. A., Friend, D. S. and Papahadjopoulos, D., 1985, Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes. Biochemistry, 24, 3091-3098.
18. Düzgüneş, N., Straubinger, R. M. and Papahadjopoulos, D., 1983, pH-dependent membrane fusion. Journal of Cell Biology, 97, 178a (Abstract).
19. 2+-induced fusion and destabilization of liposomes. Biochemistry, 24, 3099-3106.
20. Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K. and Haase, A. T., 1993, Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature, 362, 359-362.
21. Felgner, P. L., Tsai, Y. J., Sukhu, L., Wheeler, C. J., Manthorpe, M., Marshall, J. and Cheng, S. H., 1995, Improved cationic lipid formulations for in vivo gene therapy. Annals of the New York Academy of Sciences, 772, 126-139.
22. Fisher, R. A., Bertonis, J. M., Meier, W., Johnson, V. A., Costopoulos, D. S., Liu, T., Tizard, R., Walker, B. D., Hirsch, M. S., Schooley, R. T. and Flavell, R. A., 1988, HIV infection is blocked in vitro by recombinant soluble CD4. Nature, 331, 76-78.
23. Flasher, D., Konopka, K., Chamow, S. M., Dazin, P., Ashkenazi, A., Pretzer, E. and Düzgüneş, N., 1994, Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG). Biochimica et Biophysica Acta, 1194, 185-196.
24. Gartner, S., Markovits, P., Markovitz, D. M., Kaplan, M. H., Gallo, R. C. and Popovic, M., 1986, The role of mononuclear phagocytes in HTLV-III/LAV infection. Science , 33, 215-219.
25. Harrison, G. S., Maxwell, F., Long, C. J., Rosen, C. A., Glode, L. M. and Maxwell, I. H., 1991, Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 tat and rev proteins in transfected cells. Human Gene Therapy, 2, 53-60.
26. Hirsch, M. S. and D'Aquila, R. T., 1993, Therapy for human immunodeficiency virus infection. New England Journal of Medicine, 328, 1686-1695.
27. Huang, S. K., Lee, K.-D., Hong, K., Friend, D. S. and Papahadjopoulos, D., 1992, Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Research, 52, 5135-5143.
28. Hufert, F. T., Schmitz, J., Schreiber, M., Schmitz, H., Rácz, P. and von Laer, D. D., 1993, Human Kupffer cells infected with HIV-1 in vivo. Journal of Acquired Immune Deficiency Syndrome, 6, 772-777.
29. Huff, J. R., 1991, HIV protease: A novel chemotherapeutic target for AIDS. Journal of Medicinal Chemistry, 34, 2305-2314.
30. Hussey, R. E., Richardson, N. E., Kowalski, M., Brown, N. R., Chang, H. C., Siliciano, R. F., Dorfman, T., Walker, B., Sodroski, J. and Reinherz, E. L., 1988, A soluble CD4 protein selectively inhibits HIV replication and syncytium formation. Nature, 331, 78-81.
31. Johnston, M. I. and Hoth, D. F., 1993, Present status and future prospects for HIV therapies. Science, 260, 1286-1293.
32. Kageyama, S., Anderson, B. D., Hoesterey, B. L., Hayashi, H., Kiso, Y., Flora, K. P. and Mitsuya, H., 1994, Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins. Antimicrobial Agents and Chemotherapy, 38, 1107-1111.
33. Kaplan, A. H., Manchester, M. and Swanstrom, R., 1994, The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. Journal of Virology, 68, 6782-6786.
34. Kay, J. and Dunn, B. M., 1990, Viral proteinases: Weakness in strength. Biochimica et Biophysica Acta, 1048, 1-18.
35. Kempf, D. J., Marsh, K. C., Denissen, J. F., McDonald, E., Vasavanonda, S., Flentge, C. A., Green, B. E., Fino, L., Park, C. H., Kong, X.-P., Wideburg, N. E., Saldivar, A., Ruiz, L., Kati, W. M., Sham, H. L., Robins, T., Stewart, K. D., Hsu, A., Plattner, J. J., Leonard, J. M. and Norbeck, D. W., 1995, ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proceedings of the National Academy of Sciences (USA), 92, 2484-2488.
36. Kennedy, P. E., Moss, B. and Berger, E. A., 1993, Primary HIV-1 isolates refractory to neutralization by soluble CD4 are potently inhibited by CD4-Pseudomonas exotoxin. Virology, 192, 375-379.
37. Konopka, K., Düzgüneş, N., Rossi, J. and Lee, N. S., 1998, Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev binding aptamer and ribozyme DNAs. Journal of Drug Targeting, 5, 247-259.
38. Konopka, K., Harrison, G. S., Felgner, P. L. and Düzgüneş, N., 1997, Cationic liposome-mediated expression of HIV-regulated luciferase and diphtheria toxin A genes in HeLa cells infected with or expressing HIV. Biochimica et Biophysica Acta, 1356, 185-197.
39. Konopka, K., Pretzer, E., Plowman, B. and Düzgüneş, N., 1993, Long-term noncytopathic productive infection of the human monocytic leukemia cell line THP-1 by human immunodeficiency virus type 1 (HIV-1IIIB). Virology, 193, 877-887.
40. Lasic, D. D. and Templeton, N. S., 1996, Liposomes in gene therapy. Advanced Drug Delivery Reviews, 20, 221-266.
41. Lee, R. J. and Huang, L., 1996, Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. Journal of Biological Chemistry, 271, 8481-8487.
42. Lee, S.-W., Gallardo, H. F., Gilboa, E. and Smith, C., 1994, Inhibition of human immunodeficiency virus type 1 in human cells by a potent Rev response element decoy comprised of the 13-nucleotide minimal Rev-binding domain. Journal of Virology, 68, 8254-8264.
43. Levy, J. A., 1993, Pathogenesis of human immunodeficiency virus infection. Microbiological Reviews, 57, 183-289.
44. Lisziewicz, J., Sun, D., Weichold, F. F., Thierry, A. R., Lusso, P., Tang, J., Gallo, R. C. and Agrawal, S., 1994, Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells. Proceedings of the National Academy of Sciences (USA), 91, 7942-7946.
45. Liu, D., Zhou, F. and Huang, L., 1989, Characterization of plasma-stabilized liposomes composed of dioleoylphosphatidylethanolamine and oleic acid. Biochemical and Biophysical Research Communications, 162, 326-333.
46. Matsukura, M., Zon, G., Shinozuka, K., Robert-Guroff, M., Shimada, T., Stein, C. A., Mitsuya, H., Wong-Staal, F., Cohen, J. S. and Broder, S., 1989, Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells. Proceedings of the National Academy of Sciences (USA), 86, 4244-4248.
47. McDougal, J. S., Maddon, P. J., Orloff, G., Clapham, P. R., Dalgleish, A. G., Jamal, S., Weiss, R. A. and Axel, R. A., 1991, Role of CD4 in the penetration of cells by HIV. Advances in Experimental Medicine and Biology, 300, 145-158.
48. Meltzer, M. S., Skillman, D. R., Gomatos, P. J., Kalter, D. C. and Gendelman, H. E., 1990, Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annual Review of Immunology, 8, 169-194.
49. Pantaleo, G. and Fauci, A. S., 1995, New concepts in the immunopathogenesis of HIV infection. Annual Review of Immunology, 13, 487-512.
50. Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P. and Fauci, A. S., 1993, HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature, 362, 355-358.
51. Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K.-D., Woodle, M. C., Lasic, D. D., Redemann, C. and Martin, F. J., 1991, Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proceedings of the National Academy of Sciences (USA), 88, 11460-11464.
52. Pedroso de Lima, M. C., Simões, S., Pires, P., Gaspar, R., Slepushkin, V. and Düzgüneş, N., 1999, Gene delivery mediated by cationic liposomes: From biophysical aspects to enhancement of transfection. Molecular Membrane Biology, 16, 103-109.
53. Pretzer, E., Flasher, D. and Düzgüneş, N., 1997, Inhibition of human immunodeficiency virus type-1 replication in macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease. Antiviral Research, 34, 1-15.
54. Richman, D. D., 1996, HIV therapeutics. Science, 272, 1886-1889.
55. Robins, T. and Plattner, J., 1993, HIV protease inhibitors: Their anti-HIV activity and potential role in treatment. Journal of Acquired Immune Deficiency Syndrome, 6, 162-170.
56. Ropert, C., Lavignon, M., Dubernet, C., Couvreur, P. and Malvy, C., 1992, Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirus. Biochemical and Biophysical Research Communications, 183, 879-885.
57. Rossi, J. J. and Sarver, N., 1992, Catalytic antisense RNA (ribozymes): Their potential and use as anti-HIV-1 therapeutic agents. Advances in Experimental Medicine and Biology, 312, 95-109.
58. Sarver, N. and Rossi, J., 1993, Gene therapy: A bold direction for HIV-1 treatment. AIDS Research and Human Retroviruses, 9, 483-487.
59. Scanlon, K. J., Ohta, Y., Ishida, H., Kijima, H., Ohkawa, T., Kaminski, A., Tsai, J., Horng, G. and Kashani-Sabet, M., 1995, Oligonucleotide-mediated modulation of mammalian gene expression. FASEB Journal, 9, 1288-1296.
60. Simões, S., Slepushkin, V., Gaspar, R., Pedroso de Lima, M. C. and Düzgüneş, N., 1998, Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides. Gene Therapy, 5, 955-964.
61. Singhal, A. and Huang, L., 1994, Gene transfer in mammalian cells using liposomes as carriers. In Gene Therapeutics: Methods and Applications of Direct Gene Transfer, edited by J. A. Wolf (Boston: Birkhäuser), pp. 118-142.
62. Slepushkin, V. A., Salem, I. I., Andreev, S. M., Dazin, P. and Düzgüneş, N., 1996, Targeting of liposomes to HIV-infected cells by peptides derived from the CD4 receptor. Biochemical and Biophysical Research Communications, 227, 827-833.
63. Slepushkin, V. A., Simões, S., Dazin, P., Newman, M. S., Guo, L. S., Pedroso de Lima, M. C. and Düzgüneş, N., 1997, Sterically stabilized pH-sensitive liposomes: Intracellular delivery of aqueous contents and prolonged circulation in vivo. Journal of Biological Chemistry, 272, 2382-2388.
64. Smith, D. H., Byrn, R. A., Marsters, S. A., Gregory, T., Groopman, J. E. and Capon, D. J., 1987, Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science, 238, 1704-1707.
65. Stein, C. A. and Cheng, Y. C., 1993, Antisense oligonucleotides as therapeutic agents-Is the bullet really magical. Science, 260, 1004-1012.
66. Straubinger, R. M., Düzgüneş, N. and Papahadjopoulos, D., 1985, pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Letters, 179, 148-154.
67. 1' phenyl substituents: X-ray crystal structure assisted design. Journal of Medicinal Chemistry, 35, 1685-1701.
68. Tonkinson, J. L. and Stein, C. A., 1993, Antisense nucleic acids-prospects for antiviral intervention. Antiviral Chemistry and Chemotherapy, 4, 193-200.
69. Traunecker, A., Luke, W. and Karjalainen, K., 1988, Soluble CD4 molecules neutralize human immunodeficiency virus type 1. Nature, 331, 84-86.
70. Tuerk, C. and MacDougal-Waugh, S., 1997, In vitro evolution of functional nucleic acids: high-affinity RNA ligands of HIV-1 proteins. Gene, 137, 33-39.
71. Turner, S., Tizard, R., DeMarinis, J., Pepinsky, R. B., Zullo, J., Schooley, R. and Fisher, R., 1992, Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. Proceedings of the National Academy of Sciences (USA), 89, 1335-1339.
72. Wagner, R. W. and Flanagan, W. M., 1997, Antisense technology and prospects for therapy of viral infections and cancer. Molecular Medicine Today, 3, 31-38.